Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling Methods An, Ming-Wen , Han, Yu , Meyers, Jeffrey P. , Bogaerts, Jan ... - - J. Clin. Oncol - 2015 Manuscript - Secondary-not-in-original - Primary - GI - NCCTG-N9741
Exploring the statistical and clinical impact of two interim analyses on the phase II design with option for direct assignment An, Ming-Wen , Mandrekar, Sumithra J. , Edelman, Martin J. ... - - Contemp Clin Trials - 2014 Manuscript - Secondary-not-in-original - Primary - Respiratory - CALGB-30203
Missing tumor measurement (TM) data in the search for alternative TM-based endpoints in cancer clinical trials An, Ming-Wen , Tang, Jun , Grothey, Axel , Sargent, Daniel J. ... - - Contemp Clin Trials Commun - 2019 Manuscript - Secondary-not-in-original - Primary - GI - A151817 , N0026 , N9741 , NCCTG-N9741
Evaluation of the Optimal Number of Lesions Needed for Tumor Evaluation Using the Response Evaluation Criteria in Solid Tumors: A North Central Cancer Treatment Group Investigation Hillman, Shauna L. , An, Ming-Wen , O'Connell, Michael J. ... - - J Clin Oncol - 2009 Manuscript - Secondary-not-in-original - Comprehensive - GI - N9741
